Home › NDC Lookup › RxCUI directory › RxCUI 1736786

Oxaliplatin 100 MG Injection — RxCUI 1736786

RxNorm drug concept · Semantic clinical drug
RxCUI 1736786 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1736786
Official nameOxaliplatin 100 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped4
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Oxaliplatin Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Oxaliplatin is a chemotherapy drug that works by damaging the DNA inside cancer cells, stopping them from growing and dividing. It's always used alongside two other drugs — fluorou...
  • Why am I getting oxaliplatin — what is it actually doing for my cancer?
  • That's called peripheral neuropathy, and it's one of the most common side effects with oxaliplatin — so you're not imagining it, and you're not alone. There are two types. The firs...
  • I keep hearing about the tingling and numbness — what's that about, and will it go away?
📖 Read our full Oxaliplatin Injection guide →

🕸️ Concept Web — How Oxaliplatin 100 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Oxaliplatin 100 MG Injection RxCUI 1736786

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Oxaliplatin 32592
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Oxaliplatin Injection 1736775
    • Oxaliplatin Injectable Product 1160121
    • Injection 1649574
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Oxaliplatin 100 MG 1736785

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Oxaliplatin 100 MG SCDC · 1736785
  • Oxaliplatin Injection SCDF · 1736775
  • Oxaliplatin Injectable Product SCDG · 1160121

📦 FDA Products & Package NDCs

4 products · 4 package NDCs
4 package NDCs map to RxCUI 1736786 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
67184-0501-01 1 VIAL, SINGLE-DOSE in 1 CARTON (67184-0501-1) / 10 mL in 1... Oxaliplatin Qilu Pharmaceutical Co., Ltd. 2016-05-11
67184-0502-01 1 VIAL, SINGLE-DOSE in 1 CARTON (67184-0502-1) / 20 mL in 1... Oxaliplatin Qilu Pharmaceutical Co., Ltd. 2016-05-11
68083-0170-01 10 mL in 1 VIAL (68083-170-01) Oxaliplatin Gland Pharma Limited 2017-05-29
68083-0171-01 20 mL in 1 VIAL (68083-171-01) Oxaliplatin Gland Pharma Limited 2017-05-29
Observed labelers: Gland Pharma Limited (2) · Qilu Pharmaceutical Co., Ltd. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.